CubaHeadlines

Nimotuzumab

Nimotuzumab: Explore the Cuban-developed cancer drug gaining international acclaim, approved in Russia for targeting specific tumors. Stay informed on its advancements.

Cuban-Developed Cancer Drug Gains Approval in Russia for Specific Tumor Treatments
Cuban-Developed Cancer Drug Gains Approval in Russia for Specific Tumor Treatments

Published on 10/19/2026